Antifungal Stewardship in Clinical Practice

Summary

Antifungal stewardship encompasses coordinated interventions designed to optimise the use of systemic antifungal agents, improve patient outcomes and minimise the emergence of drug-resistant fungi. Programmes integrate evidence-based guidelines with multidisciplinary collaboration among infectious-disease specialists, pharmacists, microbiologists and front-line clinicians. Core strategies include timely and accurate diagnostics, therapeutic drug monitoring, dose adjustment for organ function and drug–drug interactions, and clear criteria for initiation and de-escalation of therapy. Education and audit with feedback underpin sustainable change, while consumption metrics and process-outcome measures track impact on prescribing patterns, clinical responses and cost-effectiveness. Globally, stewardship efforts address diverse settings—from intensive care units grappling with COVID-19-associated fungal superinfections to immunocompromised populations at risk of invasive disease—highlighting the need for adaptable models that preserve antifungal efficacy and ensure equitable access.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Antifungal Stewardship in Clinical Practice publication trend

The graph below shows the total number of articles in antifungal stewardship in clinical practice across all publications each year (not limited to Nature Index journals).

Technical terms

Antifungal stewardship: A coordinated programme to optimise antifungal use, balancing patient outcomes with resistance prevention.

Invasive fungal infection (IFI): A severe infection in which fungi invade sterile body sites, such as bloodstream or deep tissues.

Therapeutic drug monitoring (TDM): Measurement of drug concentrations in blood to adjust dosing for efficacy and minimise toxicity.

Empirical therapy: Initiation of antifungal treatment based on clinical suspicion before pathogen identification.

Prophylaxis: Preventive administration of antifungal agents to high-risk patients to avert infection.

Drug–drug interaction: A pharmacological interaction where one drug alters the effect or metabolism of another, requiring dose adjustment.

Consumption metrics: Quantitative measures (e.g. days of therapy per 1,000 patient-days) tracking antimicrobial use over time.

References

  1. Evaluation of Systemic Antifungal Prescribing Knowledge and Practice in the Critical Care Setting among ICU Physicians and Clinical Pharmacists: A Cross-Sectional Study. Antibiotics (2023).
  2. Antifungal Stewardship Interventions in Patients with Hematologic Malignancies. Current Fungal Infection Reports (2023).
  3. Impact of COVID-19 pandemic on antifungal consumption: a multicenter retrospective analysis. Critical Care (2022).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Index 2026 Regenerative medicine

Regenerative medicine has the potential to transform the treatment of chronic and life-threatening diseases. But major challenges remain, such as overcoming immune rejection and ensuring that new therapies are developed using more inclusive data sets. In this supplement, we explore the discoveries that are driving the field, the barriers that could limit its progress, and the teams and institutions that are making their mark.

Nature Index 2026 Regenerative medicine
Access for free
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.